High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US10793892B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10793892-B2 |
| Application number | US-201214358839-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 16, 2012 |
| Priority date | Nov 18, 2011 |
| Publication date | Oct 6, 2020 |
| Grant date | Oct 6, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for detecting the presence of expanded-spectrum ß-lactamase (ß-lactamase hydrolyzing expanded-spectrum cephalosporin)-producing bacteria in a sample, said method comprising the steps of: a) performing cell lysis on a test sample in order to obtain an enzymatic suspension; b) reacting a fraction of the enzymatic suspension obtained in step a) with a reagent kit, said reagent kit comprising —expanded-spectrum ß-lactamase substrate selected from the group consisting of cephalosporins, aztreonam, and cephamycins, —a pH color indicator which will change color when the pH of the reaction mixture is comprised between 6.4 and 8.4, wherein a color change after step b) indicates the presence of expanded-spectrum ß-lactamase-producing bacteria in the test sample. The invention also relates to a reagent kit, to a microtiter plate and to their uses in detecting the presence of expanded-spectrum ß-lactamase producers in a test sample.
Opening claim text (preview).
The invention claimed is: 1. A method for detecting the presence of expanded-spectrum ß-lactamase-producing bacteria in a blood or urine sample, said method comprising the steps of: a) performing cell lysis on the blood or urine sample in order to obtain an enzymatic suspension, wherein said bacteria in said blood or urine sample are not cultured to isolate said bacteria prior to step a); b) reacting a fraction of the enzymatic suspension obtained in step a) with a reagent kit, said reagent kit comprising an expanded-spectrum ß-lactamase (EBSL) substrate selected from cephalosporins and aztreonam; and, a pH color indicator which will change color when the pH of the reaction mixture is from 6.4 and 8.4, wherein a color change visually observed within 5 minutes to 120 minutes after the beginning of step b) indicates the presence of expanded-spectrum ß-lactamase-producing bacteria in the blood or urine sample. 2. The method according to claim 1 , wherein the expanded-spectrum ß-lactamase-producing bacteria are selected from the group consisting of Acinetobacter, Aeromonas, Bacillus, Bacteroides, Citrobacter, Enterobacter, Escherichia, Klebsiella, Morganella, Pandoreae, Proteus, Providencia, Pseudomonas, Ralstonia, Raoultella, Salmonella, Serratia, Shewanella, Shigella and Stenotrophomonas. 3. The method according to claim 1 , wherein reaction in step b) is carried out at a temperature between 15° C. and 40° C. 4. A method according to claim 1 , wherein the ESBL substrate is cefotaxime, wherein the pH color indicator is phenol red, and wherein the color change is from red to yellow. 5. The method according to claim 1 , wherein reaction in step b) is carried out at a temperature between 20° C. and 37° C. 6. The method according to claim 1 , wherein the reaction in step b) is carried out over a period of time sufficient to observe a color change. 7. The method according to claim 1 , wherein the reaction in step b) is carried out over a period of time between 20 minutes and 40 minutes. 8. The method according to claim 1 , wherein the expanded-spectrum ß-lactamase substrate which is a cephalosporin or an aztreonam is selected from the group consisting of cefotaxime, ceftriaxone, ceftazidime, cefepime, and cefpirome.
Measuring or testing processes involving enzymes, nucleic acids or microorganisms (measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34); Compositions therefor; Processes of preparing such compositions · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
involving hydrolase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.